---
title: "AppYea, Inc. | 10-Q: FY2025 Q3 Revenue: USD 2 K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266618245.md"
datetime: "2025-11-19T21:16:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266618245.md)
  - [en](https://longbridge.com/en/news/266618245.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266618245.md)
generator: "portal-rs"
---

# AppYea, Inc. | 10-Q: FY2025 Q3 Revenue: USD 2 K

Revenue: As of FY2025 Q3, the actual value is USD 2 K.

EPS: As of FY2025 Q3, the actual value is USD 0.

### Segment Revenue

-   Revenues for the three months ended September 30, 2025, were $2,000, compared to $1,000 for the same period in 2024. For the nine months ended September 30, 2025, revenues were $6,000, compared to $16,000 in 2024. All revenues were from sales of the AppySleep wristband.

### Operational Metrics

-   Gross profit for the three months ended September 30, 2025, was $1,000, compared to a loss of $1,000 in 2024. For the nine months ended September 30, 2025, the gross loss was $3,000, compared to a profit of $8,000 in 2024.
-   Operating loss for the three months ended September 30, 2025, was $237,000, compared to $610,000 in 2024. For the nine months ended September 30, 2025, the operating loss was $713,000, compared to $1,415,000 in 2024.
-   Net loss for the three months ended September 30, 2025, was $4,678,000, compared to $512,000 in 2024. For the nine months ended September 30, 2025, the net loss was $4,850,000, compared to $1,575,000 in 2024.

### Cash Flow

-   Net cash used in operating activities for the nine months ended September 30, 2025, was $350,000, compared to $569,000 in 2024.
-   Net cash provided by financing activities for the nine months ended September 30, 2025, was $735,000, compared to $486,000 in 2024.

### Unique Metrics

-   The company has an accumulated deficit of $15,208,000 as of September 30, 2025, and a stockholders’ deficiency of $7,758,000.

### Future Outlook and Strategy

-   **Core Business Focus**: The company is focusing on the development and commercialization of its digital health products, including the AppySleep wristband and AppySleep LAB app, with plans to file for FDA approval.
-   **Non-Core Business**: The company has entered into a strategic pivot towards the institutional lottery market through a transaction with Techlott Enterprises Ltd., acquiring a blockchain-based lottery and gaming platform.
-   **Priority**: The company aims to complete the adaptation of the Techlott platform for new applications by the end of the year and begin commercial pilots with licensed operators.

### Related Stocks

- [APYP.US](https://longbridge.com/en/quote/APYP.US.md)
- [LOTT.US](https://longbridge.com/en/quote/LOTT.US.md)

## Related News & Research

- [Techlott Signs Definitive Five-Year Platform Agreement with The Gambia’s Exclusive Lottery and Gaming License Holder | APYP Stock News](https://longbridge.com/en/news/295677814.md)
- [AppYea Delays Annual 10-K Filing Briefly](https://longbridge.com/en/news/281286342.md)
- [APPYEA Inc. Announces Corporate Rebranding: Changes Name to TECHLOTT Inc. and Ticker Symbol to LOTT | LOTT Stock News](https://longbridge.com/en/news/288590945.md)
- [AppYea Delays Quarterly Filing Amid Strategic Shift](https://longbridge.com/en/news/286624185.md)
- [TechLott Q2 FY26 net loss widens to USD 1.87 million; revenue posts no revenue](https://longbridge.com/en/news/295943131.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**